Single and Multiple Dose Study in Japanese Subjects

Completed · Phase 1 · Has a placebo group

Conditions studied: Gout

In brief

This study will explore the safety, tolerability, and serum uric acid lowering effect of RDEA3170 in healthy Japanese males to allow comparison with the Western population.

Key facts

Study ID
NCT01872832
Run by
Ardea Biosciences, Inc.
People needed
46
Starts
2013-06-01
Expected to finish
2013-11-01
Last updated by the study team
2014-01-09

Who can join

Age: 20 and older, up to 55. Sex: male. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.